JD... "From a proof of concept standpoint it would serve no purpose because xB3 is not a therapeutic. xB3 really only makes sense as an attachment to a therapeutic payload, a drug."
So there will be many Phase 1 Trials with each new Therapeutic payload piggybacking xB3?
Koo